Lawrence E. Bullock
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Lawrence E. Bullock
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Generic | 17 | |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.
15
| Extinct | Miscellaneous Commercial Services | 15 |
| Subsidiary | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lawrence E. Bullock
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Masters Business Admin Undergraduate Degree | |
| Indiana University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Founder Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director of Finance/CFO Chief Executive Officer | |
| University of Phoenix | College/University | Undergraduate Degree Graduate Degree | |
| Williams College | College/University | Undergraduate Degree Undergraduate Degree | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Founder | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Administrative Officer Chief Administrative Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| San Diego State University | College/University | Masters Business Admin Undergraduate Degree | |
| New York Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
| Michigan State University | College/University | Undergraduate Degree | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
| Duke University Medical Center | College/University | Corporate Officer/Principal | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Chairman | |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| Brown University | College/University | Undergraduate Degree | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Founder | |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Doctorate Degree | |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York. | Investment Managers | Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 47 |
| Deutschland | 2 |
| Vereinigtes Königreich | 2 |
| Belgien | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 296 |
| Corporate Officer/Principal | 114 |
| Independent Dir/Board Member | 59 |
| Chairman | 43 |
| Undergraduate Degree | 37 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Bryan Roberts | 44 |
| Arnold Lewis Oronsky | 35 |
| Bruce Peacock | 28 |
| David Guyer | 27 |
| Chris Christoffersen | 24 |
| Anne VanLent | 23 |
| R. Greer | 23 |
| Jill Carroll | 19 |
| Ivana Magovcevic-Liebisch | 18 |
| John Spencer | 17 |
| James Niedel | 14 |
| Douglas Fambrough | 14 |
| Daniel L. Menichella | 13 |
| Lawrence Blatt | 13 |
- Börse
- Insiders
- Lawrence E. Bullock
- Unternehmensverbindungen
